Gene Expression Changes in Mucopolysaccharidosis
Author Information
Author(s): Karolina Wiśniewska, Magdalena Żabińska, Aneta Szulc, Lidia Gaffke, Grzegorz Węgrzyn, Karolina Pierzynowska, Ritva Tikkanen
Primary Institution: Department of Molecular Biology, Faculty of Biology, University of Gdansk
Hypothesis
The study aims to analyze shared and specific gene expression alterations in neuronopathic and non-neuronopathic types of mucopolysaccharidosis.
Conclusion
The study identified common and specific gene expression changes in mucopolysaccharidosis, suggesting potential biomarkers for neurodegeneration.
Supporting Evidence
- Approximately 300 transcripts showed altered expression in MPS II, IVA, and VI.
- Almost 900 transcripts were altered in MPS IIIA, IIIB, IVB, and IX.
- PFN1 was the only gene with increased expression in all MPS types/subtypes.
- 418 unique genes were identified with altered expression in neuronopathic MPS types.
Takeaway
This study looked at how genes behave differently in two types of a disease called mucopolysaccharidosis, helping us understand which genes might be important for brain problems.
Methodology
The study used transcriptomic analyses based on RNA-seq to compare gene expression in fibroblasts from patients with different types of mucopolysaccharidosis.
Limitations
The study used only one cell line per MPS type/subtype due to the rarity of the disease.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website